Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Zignol

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Tropical Medicine and Infectious Disease|April 27, 2023
Scaling Up TB Screening and TB Preventive Treatment Globally: Key Actions and Healthcare Service CostsSrinath Satyanarayana, Carel Pretorius, Avinash Kanchar, et al.
The European Respiratory Journal|August 29, 2020
Ongoing challenges to understanding multidrug- and rifampicin-resistant tuberculosis in children <i>versus</i> adultsC Finn McQuaid, Ted Cohen, Anna S Dean, et al.
Plos One|May 12, 2016
Use of Lot Quality Assurance Sampling to Ascertain Levels of Drug Resistant Tuberculosis in Western KenyaJulia Jezmir, Ted Cohen, Matteo Zignol, et al.
The European Respiratory Journal|September 28, 2014
Multidrug-resistant tuberculosis around the world: what progress has been made?Dennis Falzon, Fuad Mirzayev, Fraser Wares, et al.
The Journal of Infectious Diseases|July 18, 2006
Global incidence of multidrug-resistant tuberculosisMatteo Zignol, Mehran S Hosseini, Abigail Wright, et al.
Epidemiology (Cambridge, Mass.)|January 18, 2012
Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance samplingBethany Lynn Hedt, Frank van Leth, Matteo Zignol, et al.
Tropical Medicine & International Health : TM & IH|January 22, 2019
Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance surveyVibol Iem, Anna Dean, Matteo Zignol, et al.
Plos One|March 23, 2016
The Burden of Drug-Resistant Tuberculosis in Papua New Guinea: Results of a Large Population-Based SurveyPaul Aia, Margaret Kal, Evelyn Lavu, et al.
The European Respiratory Journal|October 27, 2012
Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden countryHelen E Jenkins, Valeriu Plesca, Anisoara Ciobanu, et al.
Vaccine|November 18, 2019
Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organization consultationsJohan Vekemans, Michael James Brennan, Mark Hatherill, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Tropical Medicine and Infectious Disease|April 27, 2023
Scaling Up TB Screening and TB Preventive Treatment Globally: Key Actions and Healthcare Service CostsSrinath Satyanarayana, Carel Pretorius, Avinash Kanchar, et al.
The European Respiratory Journal|August 29, 2020
Ongoing challenges to understanding multidrug- and rifampicin-resistant tuberculosis in children <i>versus</i> adultsC Finn McQuaid, Ted Cohen, Anna S Dean, et al.
Plos One|May 12, 2016
Use of Lot Quality Assurance Sampling to Ascertain Levels of Drug Resistant Tuberculosis in Western KenyaJulia Jezmir, Ted Cohen, Matteo Zignol, et al.
The European Respiratory Journal|September 28, 2014
Multidrug-resistant tuberculosis around the world: what progress has been made?Dennis Falzon, Fuad Mirzayev, Fraser Wares, et al.
The Journal of Infectious Diseases|July 18, 2006
Global incidence of multidrug-resistant tuberculosisMatteo Zignol, Mehran S Hosseini, Abigail Wright, et al.
Epidemiology (Cambridge, Mass.)|January 18, 2012
Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance samplingBethany Lynn Hedt, Frank van Leth, Matteo Zignol, et al.
Tropical Medicine & International Health : TM & IH|January 22, 2019
Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance surveyVibol Iem, Anna Dean, Matteo Zignol, et al.
Plos One|March 23, 2016
The Burden of Drug-Resistant Tuberculosis in Papua New Guinea: Results of a Large Population-Based SurveyPaul Aia, Margaret Kal, Evelyn Lavu, et al.
The European Respiratory Journal|October 27, 2012
Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden countryHelen E Jenkins, Valeriu Plesca, Anisoara Ciobanu, et al.
Vaccine|November 18, 2019
Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organization consultationsJohan Vekemans, Michael James Brennan, Mark Hatherill, et al.
Pageof 9